AMTB Amerant Bancorp Inc.

NYSE National Commercial Banks FL CIK: 0001734342
AI RATING
SELL
72% Confidence

Investment Thesis

Amerant Bancorp exhibits a genuine operational turnaround with 65.6% revenue growth and 432.8% net income expansion, but fundamental financial health indicators remain critically weak. Interest coverage of 0.3x signals severe difficulty meeting debt obligations, while ROE of 2% and ROA of 0.2% demonstrate the bank remains unable to generate acceptable returns on its capital base despite operational recovery.

Strengths

  • + Exceptional revenue growth of 65.6% YoY demonstrates strong business momentum and market position improvement
  • + Dramatic earnings turnaround with net income and EPS growth of 432.8% and 386.4% respectively indicates genuine recovery from prior loss period
  • + Zero traditional long-term debt (0.00x Debt/Equity ratio) provides balance sheet stability and financial flexibility

Risks

  • ! Critical: Interest coverage ratio of 0.3x indicates severe inability to service interest obligations from operating income, suggesting debt distress
  • ! ROE of 2% and ROA of 0.2% are unsustainably low for banking institutions and signal poor capital efficiency and profitability despite revenue growth
  • ! Weak free cash flow conversion (7.6% FCF margin vs 13.4% net margin) raises questions about earnings quality and sustainability of reported profits
  • ! High inherent leverage in banking model (9.9B assets with only 0.9B equity) limits downside protection in adverse scenarios

Key Metrics to Watch

Financial Metrics

Revenue
133.0M
Net Income
17.9M
EPS (Diluted)
$0.44
Free Cash Flow
10.1M
Total Assets
9.9B
Cash
188.7M

Profitability Ratios

Gross Margin N/A
Operating Margin 17.2%
Net Margin 13.4%
ROE 2.0%
ROA 0.2%
FCF Margin 7.6%

Balance Sheet & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
0.00x
Debt/Assets
90.8%
Interest Coverage
0.34x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-06T11:35:31.646130 | Data as of: 2026-03-31 | Powered by Claude AI